Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00922727 · ClinicalTrials.gov registry record · Phase 1
Safety of Lactobacillus Reuteri (L. Reuteri) in Healthy Adults
A Phase 1 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT00922727 is a Phase 1 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 40 participants.
The verdict
NCT00922727, a Phase 1 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study will evaluate the safety and tolerability of the probiotic Lactobacillus reuteri (LR) in healthy adult patients. Patients will be randomized to receive either LR or placebo orally each day for a total of 60 doses. The effects on fecal bacteria, circulating white blood cell receptors and inflammatory cytokine profiles will be measured.
Interventions
- BIOLOGICAL L. reuteri
- BIOLOGICAL Sunflower Oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00922727
The ClinicalTrials.gov registry entry for NCT00922727 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which L. reuteri is the first listed.
NCT00922727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00922727 about?
NCT00922727 is a clinical study titled "Safety of Lactobacillus Reuteri (L. Reuteri) in Healthy Adults". This study will evaluate the safety and tolerability of the probiotic Lactobacillus reuteri (LR) in healthy adult patients. Patients will be randomized to receive either LR or placebo orally each day for a total of 60 doses. The effects on fecal bacteria, circulating white blood cell receptors and i...
What is the current status of trial NCT00922727?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2009-10. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00922727?
The interventions under investigation include: L. reuteri (BIOLOGICAL), Sunflower Oil (BIOLOGICAL).
Who is sponsoring clinical trial NCT00922727?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.